Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Cazzola

Showing results (291-300 of 645) with videos related to

Pageof 65
Sort By:
COPD|July 29, 2017
Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysisMario Cazzola, Paola Rogliani, Luigino Calzetta, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 13, 2018
How does race/ethnicity influence pharmacological response to asthma therapies?Mario Cazzola, Luigino Calzetta, Maria Gabriella Matera, et al.
Expert Opinion on Drug Discovery|April 14, 2025
Novel drug discovery strategies for chronic obstructive pulmonary disease: the latest developmentsLuigino Calzetta, Elena Pistocchini, Shima Gholamalishahi, et al.
Expert Opinion on Pharmacotherapy|February 28, 2026
Emerging pharmacotherapies in chronic rhinosinusitis with nasal polypsMaria Gabriella Matera, Luigino Calzetta, Alfredo De Biase, et al.
Expert Opinion on Pharmacotherapy|November 14, 2022
Current and emerging treatment modalities for bacterial rhinosinusitis in adults: a comprehensive reviewMaria Gabriella Matera, Barbara Rinaldi, Vito de Novellis, et al.
Respiratory Medicine|July 18, 2009
Biomarkers of lung damage associated with tobacco smoke in induced sputumAlessia Comandini, Paola Rogliani, Alfredo Nunziata, et al.
Lung|August 27, 2021
Use of Thiols in the Treatment of COVID-19: Current EvidenceMario Cazzola, Paola Rogliani, Sundeep Santosh Salvi, et al.
Respiratory Medicine|January 27, 2025
Efficacy and safety of long-acting muscarinic antagonists in COPD: A meta-analysis and meta-regression with a focus on agingLuigino Calzetta, Elena Pistocchini, Rossella Laitano, et al.
Expert Opinion on Drug Discovery|August 14, 2024
The discovery and development of gefapixant as a novel antitussive therapyMaria Gabriella Matera, Paola Rogliani, Clive P Page, et al.
Respiratory Medicine|November 19, 2013
Effect of indacaterol on arterial blood gases in patients suffering from acute exacerbation of COPDPaola Rogliani, Josuel Ora, Chiara Ciaprini, et al.
Pageof 65

Showing results (291-300 of 645) with videos related to

Sort By:
Pageof 65
COPD|July 29, 2017
Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysisMario Cazzola, Paola Rogliani, Luigino Calzetta, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 13, 2018
How does race/ethnicity influence pharmacological response to asthma therapies?Mario Cazzola, Luigino Calzetta, Maria Gabriella Matera, et al.
Expert Opinion on Drug Discovery|April 14, 2025
Novel drug discovery strategies for chronic obstructive pulmonary disease: the latest developmentsLuigino Calzetta, Elena Pistocchini, Shima Gholamalishahi, et al.
Expert Opinion on Pharmacotherapy|February 28, 2026
Emerging pharmacotherapies in chronic rhinosinusitis with nasal polypsMaria Gabriella Matera, Luigino Calzetta, Alfredo De Biase, et al.
Expert Opinion on Pharmacotherapy|November 14, 2022
Current and emerging treatment modalities for bacterial rhinosinusitis in adults: a comprehensive reviewMaria Gabriella Matera, Barbara Rinaldi, Vito de Novellis, et al.
Respiratory Medicine|July 18, 2009
Biomarkers of lung damage associated with tobacco smoke in induced sputumAlessia Comandini, Paola Rogliani, Alfredo Nunziata, et al.
Lung|August 27, 2021
Use of Thiols in the Treatment of COVID-19: Current EvidenceMario Cazzola, Paola Rogliani, Sundeep Santosh Salvi, et al.
Respiratory Medicine|January 27, 2025
Efficacy and safety of long-acting muscarinic antagonists in COPD: A meta-analysis and meta-regression with a focus on agingLuigino Calzetta, Elena Pistocchini, Rossella Laitano, et al.
Expert Opinion on Drug Discovery|August 14, 2024
The discovery and development of gefapixant as a novel antitussive therapyMaria Gabriella Matera, Paola Rogliani, Clive P Page, et al.
Respiratory Medicine|November 19, 2013
Effect of indacaterol on arterial blood gases in patients suffering from acute exacerbation of COPDPaola Rogliani, Josuel Ora, Chiara Ciaprini, et al.
Pageof 65